Global Fetal Alcohol Syndrome Market - Industry Trends and Forecast to 2028

Market Analysis and Insights: Global Fetal Alcohol Syndrome Market

Fetal alcohol syndrome market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 4.90% in the above-mentioned research forecast period. Increase in natality rate and rising alcohol consumption among women population.

Increasing awareness about pregnancy associated disorders and increasing adoption of changing lifestyle patterns also boost up the market growth. Moreover rising in government funding, increase in research and developmental activities and rising healthcare expenditure act as opportunity for market growth. The high side effects associated with medication, the presence of alternative treatment options, and a strict regulatory framework may hamper the global fetal alcohol syndrome market.

Fetal alcohol syndrome occurs in individuals whose mother drank alcohol during pregnancy. These can be physical problems and can also lead to learning and behavior problems. This type of disorder occurs due to passing of alcohol from mother’s blood to the growing foetus through umbilical cord. A person affected with fetal alcohol syndrome experiences low body weight, poor coordination abilities, difficulty with attention, learning disabilities, vision and hearing problems, small head size, abnormal facial features, sleep and sucking problems among others. Fetal alcohol syndrome can be treated by application of medication, behavior and education therapy, parent training among other alternative treatment approaches.

As per the data provided by CDC this has been reported that 0.2 to 1.5 infants in every 1000 live birth suffers from fetal alcohol syndrome in U.S and also increasing at a rapid rate across the world due to rising number of alcohol consumers and hence expected to provide market with the lucrative growth. It is also estimated that fetal alcohol syndrome market is growing with the CAGR of 4.90% in 2020.

This fetal alcohol syndrome market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Fetal Alcohol Syndrome Market Scope and Market Size

Fetal alcohol syndrome market is segmented on the basis of treatment, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of treatment, the fetal alcohol syndrome market is segmented into medication, behaviour and education therapy. Medication segment is further sub-segmented into antidepressants, stimulants, neuroleptics, antianxiety drugs and others.
• On the basis of end-users, the fetal alcohol syndrome market is segmented into clinics, hospitals, homecare, others.
• On the basis of distribution channel, the fetal alcohol syndrome market is segmented into direct tender, retail pharmacy, online pharmacy, others.

Fetal Alcohol Syndrome Market Country Level Analysis

Fetal alcohol syndrome market is analysed and market size information is provided by country, treatment, end-users and distribution channel as referenced above.

The countries covered in the fetal alcohol syndrome market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts for the largest market share due to increasing number of infants with FAS in every 1,000 births and rise in research and development activities and government funding. Europe is also expected to grow exponentially due to enhance the distribution channel network and higher prevalence of FAS, with reported 2.6 percent higher as compared to global prevalence. Asia-Pacific is expected to account for the largest market share due to increasing awareness about different disease and increasing alcohol consumption among women due to rising stress level among other factors.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Fetal alcohol syndrome market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Fetal Alcohol Syndrome Market Share Analysis

Fetal alcohol syndrome market competitive landscape provides details by competitor details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Fetal alcohol syndrome market.

The major players covered in the fetal alcohol syndrome market are Forest Laboratories, Wyeth, Amneal Pharms NY, GlaxoSmithKline, Eli Lilly, Schering-Plough, Allergan, Lupin Pharmaceuticals, Inc., Lundbeck Australia Pty Ltd, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Jubilant Cadista, Sandoz International GmbH, Jazz Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc., Johnson & Johnson Services, Inc., AstraZeneca, Noven Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Otsuka America Pharmaceutical, HLS Therapeutics, NICHOLAS PIRAMAL INDIA LIMITED and Pfizer, Inc among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-61374